25 of the Best Hematologists Near Me in ann arbor, MI

Dr. Ahmed is a medical hematologist/oncologist with a clinical focus on lymphoma, myeloma and coagulation disorders. She was raised in Toledo, Ohio, and completed her undergraduate training at the University of Akron. After receiving her medical degree from the Medical College of Ohio in Toledo, Dr. Ahmed completed a residency in internal medicine at Saint Joseph Mercy Hospital in Ann Arbor. She then completed fellowship training in hematology/oncology at U-M. Dr. Ahmed is highly rated in 55 conditions, according to our data. Her clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Non-Langerhans-Cell Histiocytosis, Rosai-Dorfman Disease, and Bone Marrow Aspiration. Dr. Ahmed is board certified in Hematology. Dr. Ahmed is currently accepting new patients.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma. Dr. Smith is currently accepting new patients.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy. Dr. Pettit is board certified in Hematology and Medical Oncology. Dr. Pettit is currently accepting new patients.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology. Dr. Burke is currently accepting new patients.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Hematology and Internal Medicine. Dr. Campagnaro is currently accepting new patients.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Karimi is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Karimi is currently accepting new patients.

Anamarija Perry is a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Perry is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, and T-Cell Lymphoma. Dr. Perry is board certified in Hematopathology and Pathology-Anatomic/Pathology-Clinical.

Languages: English, Spanish Activities: Running, Cycling. Awards:2023 Castle Connolly Top Doctor. Dr. Pianko is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, and Bone Marrow Transplant. Dr. Pianko is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Pianko is currently accepting new patients.

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology. Dr. Morikawa is currently accepting new patients.

Dr. Malek is a physician scientist and professor of hematology/oncology working at the University of Michigan, Ann Arbor, USA. He obtained his MD from the University of Hamburg/Germany and subsequently trained in Molecular Biology at Johns Hopkins. He completed clinical training in Internal Medicine at Baylor College of Medicine and a combined fellowship in Hematology and Oncology at Johns Hopkins and Columbia University. Dr. Malek is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Malek is board certified in Hematology. Dr. Malek is currently accepting new patients.

Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.

Craig Cole is a Hematologist practicing medicine in Ann Arbor,, Michigan. Dr. Cole is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Hemophilic Arthropathy, Hemophilia A, and Bone Marrow Aspiration. Dr. Cole is currently accepting new patients.

Vedran Radojcic is a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Radojcic is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Terebelo is currently accepting new patients.

Suman Sood is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Sood is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Hemophilia A, Deep Vein Thrombosis, Hemophilic Arthropathy, Venous Thromboembolism (VTE), and Bone Marrow Aspiration. Dr. Sood is currently accepting new patients.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology. Dr. Carty is currently accepting new patients.

Attaphol Pawarode is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Pawarode is currently accepting new patients.

Dr. Magenau is currently an Assistant Professor at the University of Michigan and the Adult Clinical BMT director of the Blood and Marrow Transplantation Program. He holds a Bachelor of Science in Biology from Pennsylvania State University, and obtained his M.D. from the Temple University in Philadelphia, Pennsylvania. Dr. Magenau then trained in internal medicine at the University of Illinois in Chicago.Dr. Magenau is the lead clinical investigator on several trials including experience in clinical HCT, responsible research practices, team science, and conducting multicenter prospective HCT clinical trials in high risk populations (Acute Myeloid Leukemia not in remission at time of HCT). He also has a background in developing, performing, and monitoring HCT studies that integrate immune analysis of human samples. Dr. Magenau is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Magenau is board certified in Hematology. Dr. Magenau is currently accepting new patients.

Dr. Girard attended the University of Michigan College of Engineering as an undergraduate and worked as a biochemical engineer manufacturing vaccines for clinical trials for five years before attending medical school at the University of Illinois. She completed her residency in Internal Medicine at Beth Israel Deaconess Hospital, a Harvard affiliated program in Boston, MA and completed her fellowship training in Hematology/Oncology at the University of Michigan in Ann Arbor MI. Dr. Girard is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Pulmonary Embolism, Antiphospholipid Syndrome, Platelet Storage Pool Deficiency, and Bernard-Soulier Syndrome. Dr. Girard is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Girard is currently accepting new patients.

Jordan Schaefer is a hematologist specializing in thrombotic disorders and disorders of hemostasis. Originally from Canton, Michigan and completed his undergraduate degree at the University of Michigan and his medical degree from Michigan State University’s College of Human Medicine. He completed Internal Medicine residency at the Mayo Clinic in Rochester, MN and then returned to the University of Michigan for a fellowship in Hematology/Oncology. Upon completion of his fellowship, Dr. Schaefer joined the Hematology/Oncology faculty at the University of Michigan and completed a master’s degree in health and health care research through the Institute of Healthcare Policy and Innovation. He is part of the University of Michigan Hemophilia and Coagulation Disorders Program. His research interests focus on health disparities in anticoagulation care, cancer associated thrombosis, antiphospholipid syndrome, and the optimal use of antiplatelet/anticoagulant therapies. He is particularly interested in applying his training in quality improvement and implementation science to improve patient care. Outside of work, he enjoys spending time with his wife, children, dog, and cat. He likes sports, reading, and cooking. Dr. Schaefer is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Deep Vein Thrombosis, Thrombectomy, and Stent Placement. Dr. Schaefer is board certified in Internal Medicine, Hematology, and Medical Oncology.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma. Dr. Enzler is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Enzler is currently accepting new patients.

John Maciejewski is a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Maciejewski is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Maciejewski is currently accepting new patients.

Dr. Noah Brown received a B.S. in Biology from Stanford University in Stanford, California in 1999 and an M.D. from the University of Michigan in 2004. He also pursued both residency and fellowship training at the University of Michigan. His training included a residency in Anatomic and Clinical Pathology (2008-2013), and fellowships in Hematopathology (2011-2012) and Molecular and Genetic Pathology (2013-2014).Dr. Brown is board certified in Anatomic and Clinical Pathology, Hematopathology and Molecular and Genetic Pathology. He was recently awarded the Association for Molecular Pathology Young Investigator Award. He joined the faculty of the Department of Pathology at the University of Michigan in 2014 as an Assistant Professor. He is now the Medical Director of the Molecular Diagnostics Laboratory. Dr. Brown is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Childhood Acute Myeloid Leukemia, and Acute Myeloid Leukemia (AML). Dr. Brown is board certified in Hematopathology, Pathology-Anatomic/Pathology-Clinical, and Pathology-Molecular Genetic.